Literature DB >> 1200045

Expansion of intravascular volume and fetal outcome in patients with chronic hypertension and pregnancy.

F Arias.   

Abstract

Measurements of blood volume were carried out between 24 and 40 weeks of gestation in 20 multiparous patients with chronic hypertension and pregnancy. Hypertensive patients had both reduced blood volume and infants of smaller weight (p less than 0.01) than nonhypertensive control subjects. There was a significant difference (p less than 0.01) in the degree of blood volume expansion in hypertensive mothers who were delivered of infants who were adequate for gestational age (AGA), term, or premature, compared to those who were delivered of infants who were small for gestational age (SGA) or stillborn. Classification of chronic hypertension during pregnancy according to the American Committee on Maternal Welfare classification or according to severity of the hypertension was of no value in identifying the mothers at risk of delivering intrauterine growth-retarded infants. However, failure in achieving a blood volume expansion of at least 60 c.c. per kilogram clearly identified those pregnancies leading to growth retardation and fetal death. The decrease or lack of intravascular volume expansion was reflected in the presence of creatinine clearance values at nonpregnant levels in the mothers who were delivered of SGA infants and in a significant reduction below the nonpregnant levels in those who were delivered of stillborn infants. These data suggest that measurement of blood volume and endogenous creatinine clearance in patients with chronic hypertension and pregnancy is a useful parameter in the identification of those patients who will have a poor fetal outcome.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1200045     DOI: 10.1016/0002-9378(75)90883-2

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  5 in total

Review 1.  Essential hypertension and pregnancy.

Authors:  R A Bear; N Erenrich
Journal:  Can Med Assoc J       Date:  1978-04-22       Impact factor: 8.262

2.  Intrauterine growth retardation.

Authors:  M L Chiswick
Journal:  Br Med J (Clin Res Ed)       Date:  1985-09-28

3.  Maternal plasma volume and disorders of pregnancy.

Authors:  C W Redman
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-31

4.  Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy.

Authors:  E D Gallery; D M Saunders; S N Hunyor; A Z Györy
Journal:  Br Med J       Date:  1979-06-16

Review 5.  Vascular Dysfunction in Preeclampsia.

Authors:  Megan A Opichka; Matthew W Rappelt; David D Gutterman; Justin L Grobe; Jennifer J McIntosh
Journal:  Cells       Date:  2021-11-06       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.